Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Haematology & Bone Marrow Transplant
Cytogenetic study of the bone marrow
What a cytogenetic study of the bone marrow is, how chromosome analysis and karyotyping work on marrow cells, what the diagnostic evidence confirms for leukaemia and blood disorders, how it compares with FISH and molecular testing, approximate costs in Turkey compared with the UK, US and Germany, test timelines, procedure recovery, risks and how to choose an accredited haematology clinic.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Haematology & Bone Marrow Transplant
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Cytogenetic Study of the Bone Marrow
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Cytogenetic study of the bone marrow: what it is and how it works
A cytogenetic study of the bone marrow is a specialised laboratory test that examines the structure and number of chromosomes in blood-forming cells. Using bone marrow aspirate from the pelvic bone, cytogeneticists inspect dividing cells in metaphase, assemble a visual karyotype, and detect chromosomal abnormalities. Clinicians use these findings to diagnose haematological disorders, classify leukaemias, assess prognosis, and monitor response to therapy. Patients arranging a cytogenetic study of the bone marrow in Turkey often access testing through oncology treatments in Turkey.
Unlike routine blood tests, bone marrow cytogenetics directly evaluates hematopoietic stem cells at their source. Stained chromosomes reveal light and dark bands under a microscope, identifying translocations, deletions, or extra chromosomes. This guide outlines how chromosome analysis works, what evidence confirms, comparative costs across Turkey, the UK, the US, and Germany, recovery after sampling, and how to verify an accredited laboratory.
How is bone marrow cytogenetic analysis performed in the laboratory?
The analysis follows five laboratory stages once the aspirate arrives in sodium heparin tubes. First, marrow cells are cultured in nutrient media at 37°C for 24 to 48 hours without artificial mitogens, allowing abnormal clones to divide naturally. Second, a spindle inhibitor called colcemid halts dividing cells in metaphase, when chromosomes are condensed and visible.
Third, a hypotonic potassium chloride solution causes cells to swell gently, separating individual chromosomes. Fourth, a fixative of methanol and acetic acid stabilises cell structures. Finally, cells are dropped onto glass slides and stained with Giemsa dye (G-banding). A cytogeneticist examines at least 20 metaphase spreads under oil-immersion microscopy, documenting findings according to the International System for Human Cytogenomic Nomenclature (ISCN).
Does a cytogenetic study of the bone marrow provide definitive diagnoses?
Yes, conventional cytogenetics is an established diagnostic standard. Guidelines from the World Health Organization (WHO) and the European Society for Medical Oncology (ESMO) rely on chromosomal abnormalities to define blood cancers. For example, identifying the t(9;22) Philadelphia chromosome confirms chronic myeloid leukaemia and directs treatment with targeted tyrosine kinase inhibitors. Similarly, detecting t(15;17) confirms acute promyelocytic leukaemia, enabling immediate targeted therapy.
However, the test has diagnostic limits. Conventional karyotyping only detects alterations larger than 5 to 10 megabases under light microscopy. It cannot identify single nucleotide mutations or microdeletions such as FLT3, NPM1, or TP53 alterations. Furthermore, if abnormal cells fail to divide in culture, a normal report may result despite active disease. Haematologists therefore combine karyotyping with flow cytometry and molecular assays.
Cytogenetic study of the bone marrow cost in Turkey compared with the UK, US and Germany
The figures below show approximate price ranges for bone marrow aspiration and cytogenetic chromosome analysis. These figures reflect typical private healthcare fees rather than hospital quotes. Costs vary according to haematologist consultation fees, sedation, and whether supplementary FISH testing is ordered. Each clinic confirms its price in a written quotation. You can request a tailored evaluation through our free quote page.
| Country | Approximate cost range |
|---|---|
| Turkey | €400 – €1,400 |
| United Kingdom | €900 – €2,800 |
| United States | €1,600 – €5,200 |
| Germany | €1,000 – €3,000 |
What changes the cytogenetic study of the bone marrow cost: culturing complexity, added FISH panels, and whether you stay overnight. The cytogenetic study of the bone marrow price generally covers needle sampling, laboratory G-banding, and the formal ISCN report. Private hospitals in Turkey offer competitive rates because of lower operating overheads while adhering to international laboratory standards.
Karyotyping, FISH or molecular NGS panels: how do testing methods compare?
Haematologists use three main genetic testing methods when assessing bone marrow disorders. Conventional karyotyping offers a full overview across all 46 chromosomes, detecting numerical changes and unexpected translocations. Fluorescence in situ hybridization (FISH) uses fluorescent probes to examine specific gene loci in dividing and non-dividing cells, delivering rapid results within 24 to 48 hours. Next-generation sequencing (NGS) identifies point mutations at single-base resolution but cannot visualise large chromosomal rearrangements.
| Method | Best suited to | Typical limits |
|---|---|---|
| Conventional karyotyping (G-banding) | Genome-wide structural and numerical chromosome overview | Requires dividing cells; resolution limited to 5–10 megabases |
| Fluorescence in situ hybridization (FISH) | Targeted gene rearrangements and non-dividing cell analysis | Only detects targeted probes; misses unexpected abnormalities |
| Next-generation sequencing (NGS panel) | Submicroscopic gene mutations and single nucleotide variants | Does not detect large balanced translocations or karyotype architecture |
Because no single method captures every abnormality, specialists often use them together. Karyotyping establishes the overall chromosomal architecture, while FISH and NGS provide targeted confirmation and mutation profiling.
Who needs a bone marrow chromosome analysis, and when is it unsuitable?
Bone marrow chromosome testing suits patients with unexplained cytopenias (low blood counts), suspected myelodysplastic syndromes, acute leukaemias (AML or ALL), chronic myeloid leukaemia, or multiple myeloma. It is also essential for monitoring clonal evolution and evaluating remission or graft status after stem cell transplantation. Specialists coordinating complex pathways in oncology treatments in Turkey evaluate whether chromosome testing should be paired with molecular panels.
The procedure is unsuitable or must be delayed if a patient has uncorrected bleeding disorders or severe thrombocytopenia, which require platelet transfusions beforehand to minimise haematoma risk. Active skin infections over the pelvic biopsy site also prevent immediate sampling. In addition, when clinical queries involve isolated point mutations without structural rearrangements, peripheral blood molecular assays are more appropriate than marrow aspiration.
The bone marrow aspiration procedure step by step
The marrow aspiration is an outpatient procedure performed under local anaesthesia, taking approximately 15 to 30 minutes. The clinical team carries out five distinct steps:
- Positioning and cleaning: The patient lies on their stomach or side. The clinician cleans the skin over the posterior pelvic rim and applies sterile drapes.
- Local anaesthesia: Lidocaine is infiltrated into the skin, subcutaneous tissue, and the sensitive bone periosteum, causing a brief sting before complete numbness.
- Needle insertion: A specialised hollow bone marrow needle is guided through the skin into the marrow cavity using controlled pressure.
- Aspiration: A heparinised syringe draws 2 to 5 millilitres of marrow liquid. Patients feel a brief, dull drawing ache lasting a few seconds.
- Dressing: The needle is removed, firm pressure is held for several minutes to prevent bleeding, and a sterile pressure dressing is applied.
Realistic results: what a bone marrow cytogenetic report shows and what it cannot
Before testing, patients often face uncertainty from abnormal blood counts and unexplained fatigue. Understanding what the laboratory report delivers provides clarity. A completed report does not simply state positive or negative; it provides an ISCN karyotype formula detailing the chromosomes examined. A normal male result is written as 46,XY[20], whereas an abnormal finding might read 46,XX,del(5)(q13q33)[15]/46,XX[5], indicating an abnormal clone alongside normal cells.
These findings help clinical teams categorise haematological conditions into favourable, intermediate, or adverse risk groups, guiding decisions between chemotherapy and stem cell transplantation. However, cytogenetic reports have limits: they do not assess organ tolerance, cannot predict drug reactions, and do not detect submicroscopic mutations. Results must always be reviewed alongside bone marrow biopsy histology and clinical evaluations.
Your trip to Turkey and bone marrow aspiration recovery
Most patients visiting Turkey for bone marrow diagnostics stay for two to four nights. Day one involves a haematology consultation, clinical evaluation, and pre-procedure blood clotting tests. The marrow aspiration takes place on day two as an outpatient procedure. Day three allows for a wound check and initial aspirate smear review. Because laboratory cell cultures require 7 to 14 days, patients travel home to recover, receiving their formal cytogenetic report and treatment advice via secure remote consultation.
Following marrow sampling, cytogenetic study of the bone marrow recovery is straightforward. The pressure dressing stays dry for 24 to 48 hours. Most patients walk immediately and resume light daily activities the next day. Mild tenderness over the pelvic bone is normal and managed with paracetamol; avoid aspirin and ibuprofen as they increase bleeding risks. Heavy lifting and strenuous exercise should be paused for two to three days. Patients considering a cytogenetic study of the bone marrow Turkey pathway can review our guide on how it works to coordinate travel smoothly.
Risks and complications of bone marrow cytogenetic testing
Bone marrow aspiration is a standard, low-risk procedure. Clinical audits from the British Society for Haematology indicate that serious complications occur in fewer than 0.1% to 0.2% of cases. The most frequent effects are mild bruising, localised aching, and temporary tenderness at the pelvic puncture site.
Less common complications include prolonged bleeding at the puncture point, managed with direct pressure, and haematoma formation, primarily in patients with low platelet counts. Localised infection occurs in fewer than 1 in 1,000 cases under sterile technique. Allergic reactions to local anaesthetics are rare. A laboratory-specific risk is culture failure, where marrow cells fail to divide in the incubator. This occurs in 5% to 8% of cases involving hypoplastic or fibrotic marrow, requiring FISH or repeat sampling to achieve a complete result.
How to choose an accredited haematology clinic, red flags and key questions
Selecting an accredited clinic ensures reliable diagnostic results. Verify that the laboratory holds international accreditation, such as ISO 15189 for medical laboratories or College of American Pathologists (CAP) certification. Ensure bone marrow sampling is performed by experienced haematologists in a fully licensed hospital equipped for emergency care. You can learn more about clinical coordination through our guide on how it works and request comprehensive pricing through our free quote service.
Red flags include clinics that do not perform pre-procedure blood clotting tests, facilities unable to show laboratory accreditation, and providers promising that a single test detects all mutations. Trustworthy centres provide transparent timelines, deliver formal ISCN reports, and communicate clearly with your doctor at home.
Questions to ask before booking your procedure:
- Is the cytogenetics laboratory accredited to ISO 15189 or equivalent international standards?
- What clinical haematology qualifications does the doctor performing the aspiration hold?
- Does testing include conventional karyotyping alone, or are FISH panels available on the same aspirate?
- How many metaphase cells will be counted and documented in the official ISCN report?
- What is the standard turnaround time for preliminary and final written reports?
- What protocol is followed if the bone marrow cell culture fails to yield adequate dividing cells?
- How will the laboratory report and digital chromosome spreads be shared with my doctor at home?
Hospitals with Oncology in Turkey
Frequently asked questions
A cytogenetic study of the bone marrow is a laboratory test that examines the chromosomes of blood-forming cells under a microscope. By culturing cells taken from a marrow aspirate, cytogeneticists identify structural rearrangements, deletions, and extra or missing chromosomes that characterise specific leukaemias, myelodysplastic syndromes, and other haematological conditions.
Yes, karyotyping is an internationally established diagnostic standard recommended by World Health Organization guidelines. It reliably detects major numerical and structural chromosomal abnormalities across all 23 chromosome pairs in dividing cells. However, it cannot identify submicroscopic gene mutations, which requires complementary molecular testing such as next-generation sequencing.
In Turkey, chromosome analysis of bone marrow typically ranges from €400 to €1,400 depending on whether it includes aspiration, consultation, and supplementary FISH probes. In the UK, private testing often ranges between €900 and €2,800, while US hospital fees can exceed €5,000. Each clinic provides an itemised written quotation.
Before cytogenetic analysis, clinical evaluations reveal abnormal blood counts or marrow cellularity without clarifying the exact chromosomal clone. The final cytogenetic report provides an ISCN karyotype formula detailing specific translocations, additions, or deletions. This enables doctors to stratify disease risk, predict disease progression, and select targeted chemotherapy or stem cell transplant protocols.
Neither replaces the other; they are complementary. Karyotyping surveys all 46 chromosomes across the entire genome, revealing unexpected translocations or complex rearrangements. In contrast, FISH rapidly targets specific known abnormalities, even in non-dividing cells. Haematologists frequently request both tests together to obtain complete diagnostic clarity.
The skin and the periosteum covering the pelvic bone are numbed with local anaesthetic, which stings briefly. When the marrow liquid is aspirated into the syringe, patients typically feel a brief, sharp drawing or aching sensation lasting only a few seconds. Mild tenderness at the puncture site is manageable with paracetamol.
Physical recovery from marrow aspiration takes 24 to 48 hours. Most patients can walk immediately and return to desk work the following morning. The biopsy site should remain covered and dry for two days, and heavy lifting or strenuous sports should be avoided for 48 hours until local bruising settles.
Full karyotyping results typically take 7 to 14 days because marrow cells must be cultured in an incubator, arrested in metaphase, fixed, and microscopically mapped. In urgent acute leukaemia cases, preliminary FISH panels targeting key translocations can often be reported within 24 to 48 hours while full karyotyping is completed.
Bone marrow aspiration is a standard, low-risk procedure performed daily worldwide. Serious complications occur in less than 0.1% of cases according to British Society for Haematology audits. Rare risks include local infection, persistent bleeding, or haematoma formation. The laboratory cytogenetic analysis carries zero physical risk to the patient once the sample is collected.
Patients usually spend two to four nights in Turkey. This allows time for the initial haematology consultation, pre-procedure blood clotting tests, and the outpatient marrow aspiration. Because cell culturing takes 7 to 14 days, patients typically travel home to recover, receiving their formal cytogenetic report and treatment recommendations via secure digital consultation.
Patient stories